Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Puma Biotechnology, Inc. PBYI |
BLACKROCK INC BLK |
2,779,452 5.600% |
-1,047,771 (-27.38%) |
Filing History |
| 2025-02-14 12:14 pm Purchase |
2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
ACORN BIOVENTURES, L.P. | 3,940,052 8.000% |
660,612 (+20.14%) |
Filing History |
| 2025-02-14 11:11 am Sale |
2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Frazier Life Sciences Public Fund, L.P. | 0 0.000% |
-2,631,713 (Position Closed) |
Filing History |
| 2025-02-14 08:34 am Sale |
2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LP | 0 0.000% |
-2,805,000 (Position Closed) |
Filing History |
| 2025-02-03 4:00 pm Sale |
2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
MILLENNIUM MANAGEMENT LLC | 1,894,126 3.900% |
-1,270,123 (-40.14%) |
Filing History |
| 2024-11-14 12:12 pm Purchase |
2024-09-30 | 13G | Puma Biotechnology, Inc. PBYI |
ACORN BIOVENTURES, L.P. | 3,279,440 6.700% |
344,944 (+11.75%) |
Filing History |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Puma Biotechnology, Inc. PBYI |
BLACKROCK INC BLK |
3,827,223 7.800% |
0 (Unchanged) |
Filing History |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Puma Biotechnology, Inc. PBYI |
BLACKROCK INC BLK |
3,827,223 7.800% |
1,924,086 (+101.10%) |
Filing History |
| 2024-03-29 10:40 am Purchase |
2024-03-25 | 13G | Puma Biotechnology, Inc. PBYI |
Frazier Life Sciences Public Fund, L.P. | 2,631,713 5.400% |
2,631,713 (New Position) |
Filing History |
| 2024-02-14 08:19 am Sale |
2023-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LP | 2,805,000 5.900% |
-1,430,000 (-33.77%) |
Filing History |
| 2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | Puma Biotechnology, Inc. PBYI |
The Vanguard Group | 3,802,081 7.990% |
213,159 (+5.94%) |
Filing History |
| 2024-02-06 3:54 pm Purchase |
2023-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
ACORN BIOVENTURES, L.P. | 2,934,496 6.200% |
194,561 (+7.10%) |
Filing History |
| 2024-01-30 4:08 pm Purchase |
2023-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
MILLENNIUM MANAGEMENT LLC | 3,164,249 6.700% |
487,336 (+18.21%) |
Filing History |
| 2023-09-01 10:18 am Purchase |
2023-08-22 | 13G | Puma Biotechnology, Inc. PBYI |
ACORN BIOVENTURES, L.P. | 2,739,935 5.800% |
2,739,935 (New Position) |
Filing History |
| 2023-02-14 08:30 am Purchase |
2022-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Camber Capital Management LP | 4,235,000 9.280% |
2,185,000 (+106.59%) |
Filing History |
| 2023-02-09 11:30 am Sale |
2022-12-30 | 13G | Puma Biotechnology, Inc. PBYI |
The Vanguard Group | 3,588,922 7.860% |
-91,265 (-2.48%) |
Filing History |
| 2023-02-07 4:33 pm Sale |
2022-12-30 | 13G | Puma Biotechnology, Inc. PBYI |
GOLDMAN SACHS GROUP INC GS |
396,136 0.900% |
-1,701,511 (-81.12%) |
Filing History |
| 2023-01-19 4:19 pm Purchase |
2022-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
MILLENNIUM MANAGEMENT LLC | 2,676,913 5.800% |
439,214 (+19.63%) |
Filing History |
| 2022-12-12 6:35 pm Purchase |
2022-12-09 | 13D | Puma Biotechnology, Inc. PBYI |
AUERBACH ALAN H | 10,195,990 20.500% |
848,713 (+9.08%) |
Filing History |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Puma Biotechnology, Inc. PBYI |
BLACKROCK INC BLK |
1,903,137 4.200% |
-1,301,100 (-40.61%) |
Filing History |